Dr. Parker M. Normann has twenty years’ experience applying economic techniques to antitrust litigation, mergers, and regulatory matters for some of the world’s largest and best-known companies. Dr. Normann has worked on complex litigation and mergers in a variety of US and Canadian industries, including pharmaceuticals, electronics, paper products, transportation, manufacturing, and agriculture. He has also worked on matters and prepared position papers for the banking and financial markets, real estate sector, major auditing firms, and the election and political markets. Dr. Normann is well known for his ability to present complex economic concepts to technical and non-technical audiences alike.
In litigation settings, Dr. Normann has provided expert oral and written testimony at trial and in federal court and has served in various consulting and mediation engagements. Courts have cited his testimony favorably, calling it “reliable” and “persuasive,” and it has been relied on in pharmaceutical litigation as a basis for granting a rare instance of downstream discovery.
In mergers and acquisitions, Dr. Normann has advised numerous deals—often presenting before the FTC and DOJ during a second request or pull-and-refile circumstances. Of these, all have ended in a successful outcome for the combining parties.
Global Competition Review awarded Dr. Normann the 2012 Matter of the Year award for his work in the Seagate/Samsung transaction, and named him a finalist for the 2013 Economist of the Year award.
- Vice President, The CapAnalysis Group
- Head of Research, Citizens for a Sound Economy Foundation (Washington, DC)
- Litigation | 04.30.2018
- Litigation | 07.15.2016
- Business & Regulatory Consulting | 07.01.2015
- Litigation | 09.29.2014
- Business & Regulatory Consulting | 07.24.2014
- Litigation | 02.12.2014
- Business & Regulatory Consulting | 05.07.2012
- Business & Regulatory Consulting | 06.23.2011
Insights & News
- Competition Policy International (CPI) Antitrust Chronicle | 03.13.2014
Dr. Gregory Leonard and Dr. Parker Normann discuss economic issues raised by the recent ruling in the United States Department of Justice’s challenge of the Bazaarvoice acquisition of PowerReviews.
- Pharma: Pay for Delay—How Are the Courts Applying Actavis? | ABA Antitrust in Healthcare Conference 2018Event, 05.17.2018
In the 2013 case FTC v. Actavis, the Supreme Court held that drug patent settlements restricting generic entry and involving brand-to-generic payments can be anticompetitive and must be adjudicated under the rule of reason. Edgeworth Partner Dr. Parker Normann and his fellow panelists will discuss the current state of the law after almost five years and a bevy of “pay for delay” lawsuits.
- News, 07.24.2014
Dr. Parker Normann provided analysis in an SEC proposed rule change ruling.
- News, 02.12.2014
Edgeworth Partner Dr. Parker Normann provided testimony in the case involving the Federal Trade Commission’s dismissal of charges against McWane, Inc.
- Press Release, 03.19.2013
Edgeworth Economics partner and antitrust expert Dr. Parker Normann has been selected as a finalist for the Global Competition Review’s 2013 Economist of The Year award.
- News, 06.28.2012
Edgeworth antitrust expert, Dr. Normann, concludes that market definition cannot be used to determine class-wide impact in the Antitrust Practitioner.
- News, 03.28.2012
Edgeworth Economics is honored to be awarded 2012 Matter of the Year by Global Competition Review, recognizing Dr. Parker Normann who led our teams' merger review work for the Seagate/Samsung matter.
- News, 03.12.2012
Led by Dr. Parker Normann, Edgeworth Economics provided expert economic analysis on one of four disputes selected by Global Competition Review as a team finalist for 2012 Matter of the Year.
- Press Release, 03.23.2011
Washington, DC – Edgeworth Economics is proud to announce that Dr. Parker Normann, an expert in antitrust economics, has joined the firm in Washington, D.C.
Dr. Normann received his PhD in economics from George Mason University, his MS in economics from Murray State University and his BS in economics and marketing from Lehigh University.